Company
CureVac
CureVac has 13 drugs tracked on RxWires: 1 in Phase 3, 1 in Phase 2/3, 2 in Phase 2, 2 in Phase 1/2, 7 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| CVnCoV Vaccine | Phase 3 | Coronavirus |
| CVnCoV | Phase 2/3 | Covid19 |
| CVnCoV 6 μg | Phase 2 | Coronavirus |
| CV9104 | Phase 2 | Prostate Carcinoma |
| CV9103 | Phase 1/2 | Hormonal Refractory Prostate Cancer |
| CV9201 | Phase 1/2 | Non Small Cell Lung Cancer |
| CV8102 | Phase 1 | Melanoma (Skin) |
| CV9202 | Phase 1 | Non-Small Cell Lung Carcinoma |
| CV09070101 mRNA vaccine (CVHNLC) 50 µg | Phase 1 | Squamous NSCLC |
| CV7201 mRNA | Phase 1 | Rabies |
| CVSQIV | Phase 1 | Influenza |
| CV09050101 mRNA vaccine (CVGBM) 12 μg | Phase 1 | Glioblastoma |
| Rabipur® | Phase 1 | Rabies |
Latest
No recent events.
Follow CureVac on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.